Clinical Trials Browser

Interventional × Cardiotoxicity × sacubitril and valsartan sodium hydrate drug combination × Clear all

NCT05465031 2025-03-14

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Phase 4 Recruiting

Breast Diseases, Breast Neoplasms, Heart Failure, Neoplasms, Second Primary, Cardiotoxicity

NCT04092309 2020-04-03

Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation

Phase NA Unknown

Cardiotoxicity